New flow cytometry guidelines support bioAffinity’s lung cancer test
bioAffinity Technologies’ Vice President of Diagnostics, Dr Jennifer Rebeles, has contributed to a new set of guidelines for flow cytometry testing on rare matrix samples. The peer-reviewed paper, published in Cytometry Part B: Clinical Cytometry, addresses the challenges and considerations in validating assays with unique sample types.